Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lamoreaux

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Seminars in Arthritis and Rheumatism|December 15, 2021
Letter to the editor: Key safety parameters from the literature on pegloticase with immunomodulationJeff Peterson, Nathan Roe, Lissa Padnick-Silver, et al.
Physical Review Letters|November 24, 2011
New experimental limits on non-Newtonian forces in the micrometer rangeA O Sushkov, W J Kim, D A R Dalvit, et al.
The Review of Scientific Instruments|February 8, 2013
Casimir probe based upon metallized high Q SiN nanomembrane resonatorDaniel Garcia-Sanchez, King Yan Fong, Harish Bhaskaran, et al.
Jornal Brasileiro De Nefrologia|April 17, 2026
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney diseaseDhajanae Sylvertooth, Brian Bieber, Roberto Pecoits-Filho, et al.
Biotechniques|November 1, 2000
Estimation of relative mRNA content by filter hybridization to a polyuridylic probeC A Koch-Paiz, R Momenan, S A Amundson, et al.
Developmental Medicine and Child Neurology|April 18, 2001
Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label studyR Appleton, K Fichtner, L LaMoreaux, et al.
Pain|November 3, 2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scaleJohn T Farrar, James P Young, Linda LaMoreaux, et al.
Arthritis Research & Therapy|December 27, 2022
Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trialJohn K Botson, Katie Obermeyer, Brian LaMoreaux, et al.
Rheumatology and Therapy|December 7, 2020
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database StudyMegan Francis-Sedlak, Brian LaMoreaux, Lissa Padnick-Silver, et al.
ACR Open Rheumatology|August 14, 2025
Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial AnalysisYael Klionsky, Karina D Torralba, Katie Obermeyer, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Seminars in Arthritis and Rheumatism|December 15, 2021
Letter to the editor: Key safety parameters from the literature on pegloticase with immunomodulationJeff Peterson, Nathan Roe, Lissa Padnick-Silver, et al.
Physical Review Letters|November 24, 2011
New experimental limits on non-Newtonian forces in the micrometer rangeA O Sushkov, W J Kim, D A R Dalvit, et al.
The Review of Scientific Instruments|February 8, 2013
Casimir probe based upon metallized high Q SiN nanomembrane resonatorDaniel Garcia-Sanchez, King Yan Fong, Harish Bhaskaran, et al.
Jornal Brasileiro De Nefrologia|April 17, 2026
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney diseaseDhajanae Sylvertooth, Brian Bieber, Roberto Pecoits-Filho, et al.
Biotechniques|November 1, 2000
Estimation of relative mRNA content by filter hybridization to a polyuridylic probeC A Koch-Paiz, R Momenan, S A Amundson, et al.
Developmental Medicine and Child Neurology|April 18, 2001
Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label studyR Appleton, K Fichtner, L LaMoreaux, et al.
Pain|November 3, 2001
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scaleJohn T Farrar, James P Young, Linda LaMoreaux, et al.
Arthritis Research & Therapy|December 27, 2022
Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trialJohn K Botson, Katie Obermeyer, Brian LaMoreaux, et al.
Rheumatology and Therapy|December 7, 2020
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database StudyMegan Francis-Sedlak, Brian LaMoreaux, Lissa Padnick-Silver, et al.
ACR Open Rheumatology|August 14, 2025
Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial AnalysisYael Klionsky, Karina D Torralba, Katie Obermeyer, et al.
Pageof 22